Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents

dc.contributor.authorNovohradsky, Vojtech
dc.contributor.authorZamora, Ana
dc.contributor.authorGandioso, Albert
dc.contributor.authorBrabec, Viktor
dc.contributor.authorRuiz, José
dc.contributor.authorMarchán Sancho, Vicente
dc.date.accessioned2017-07-10T10:15:57Z
dc.date.available2017-07-10T10:15:57Z
dc.date.issued2017-04-25
dc.date.updated2017-07-10T10:15:57Z
dc.description.abstractA novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminiscent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.
dc.format.extent4 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec671086
dc.identifier.issn1359-7345
dc.identifier.pmid28466888
dc.identifier.urihttps://hdl.handle.net/2445/113562
dc.language.isoeng
dc.publisherRoyal Society of Chemistry
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1039/c7cc01946g
dc.relation.ispartofChemical Communications, 2017, vol. 53, p. 5523-5526
dc.relation.urihttps://doi.org/10.1039/c7cc01946g
dc.rightscc-by (c) Novohradsky, Vojtech et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)
dc.subject.classificationIridi
dc.subject.classificationCàncer
dc.subject.classificationSomatostatina
dc.subject.otherIridium
dc.subject.otherCancer
dc.subject.otherSomatostatin
dc.titleSomatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
671086.pdf
Mida:
1.87 MB
Format:
Adobe Portable Document Format